These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 22495330)
1. “Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema”. Kim SJ Retina; 2012 May; 32(5):1033; author reply 1033-4. PubMed ID: 22495330 [No Abstract] [Full Text] [Related]
2. Intravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edema. Elbendary AM; Shahin MM Retina; 2011 Nov; 31(10):2058-64. PubMed ID: 21765371 [TBL] [Abstract][Full Text] [Related]
3. Intravitreal injection of triamcinolone acetonide for diabetic macular edema. Kuhn F; Barker D Arch Ophthalmol; 2004 Jul; 122(7):1082-3; author reply 1086-8. PubMed ID: 15249385 [No Abstract] [Full Text] [Related]
4. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Wong R; Sherefat H; Bartholomew D; Horgan SE Arch Ophthalmol; 2004 Jul; 122(7):1082; author reply 1086-8. PubMed ID: 15249384 [No Abstract] [Full Text] [Related]
5. Intravitreal triamcinolone in diabetic macular edema. Aslam S; Malik N; Davies N Arch Ophthalmol; 2006 Oct; 124(10):1506-7; author reply 1507. PubMed ID: 17030730 [No Abstract] [Full Text] [Related]
6. Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Jonas JB; Degenring RF; Kamppeter BA; Kreissig I; Akkoyun I Am J Ophthalmol; 2004 Jul; 138(1):158-60. PubMed ID: 15234306 [TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide for macular edema associated with diabetic retinopathy and venous occlusive disease: it's time for clinical trials. Flynn HW; Scott IU Arch Ophthalmol; 2005 Feb; 123(2):258-9. PubMed ID: 15710825 [No Abstract] [Full Text] [Related]
8. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema. Sheth S; Rush R; Natarajan S; Gillies M Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685 [TBL] [Abstract][Full Text] [Related]
9. Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema. Ozdemir H; Karacorlu M; Karacorlu SA Am J Ophthalmol; 2005 Aug; 140(2):251-5. PubMed ID: 15992756 [TBL] [Abstract][Full Text] [Related]
17. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Kumar V; Ghosh B; Raina UK; Goel N Am J Ophthalmol; 2008 Dec; 146(6):974; author reply 974-5. PubMed ID: 19027427 [No Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab combined with/without triamcinolone acetonide in single injection for treatment of diabetic macular edema. Wang YS; Li X; Wang HY; Zhang ZF; Li MH; Su XN Chin Med J (Engl); 2011 Feb; 124(3):352-8. PubMed ID: 21362332 [TBL] [Abstract][Full Text] [Related]
19. Intravitreal cortisone injection for refractory diffuse diabetic macular edema. Ho TC; Lai WW Ophthalmologica; 2006; 220(5):349-50; author reply 350. PubMed ID: 16954717 [No Abstract] [Full Text] [Related]
20. Comparative therapy evaluation of intravitreal bevacizumab and triamcinolone acetonide on persistent diffuse diabetic macular edema. Shimura M; Nakazawa T; Yasuda K; Shiono T; Iida T; Sakamoto T; Nishida K Am J Ophthalmol; 2008 May; 145(5):854-61. PubMed ID: 18328456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]